This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1978-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978-1980
Title: Innovations by August Sturzenegger in Pharmaceutical Dosage Forms
Introduction
August Sturzenegger is a notable inventor based in Essex Fells, NJ (US). He has made significant contributions to the field of pharmaceutical dosage forms, holding a total of 2 patents. His work focuses on creating innovative and effective methods for delivering medications.
Latest Patents
Sturzenegger's latest patents include advancements in novel dosage forms. These pharmaceutical dosage forms comprise an edible web that has a particulate medicament deposited thereon or at least partially thereon. The webs are fabricated and finished to create pharmaceutically elegant solid dosage forms, ensuring that no medicament is exposed on the exterior surface. The consistency of medicament release can be controlled to exacting specifications. The solid dosage forms are prepared using high-speed automated equipment, characterized by non-destructive quality control analysis and performance evaluation conducted online and integrated into the manufacturing operation. The scope of the disclosed invention also includes certain apparatus and methods of manufacture.
Career Highlights
Sturzenegger is associated with Hoffmann-La Roche Inc., where he has been instrumental in developing innovative pharmaceutical solutions. His expertise in creating controlled-release dosage forms has positioned him as a key figure in the industry.
Collaborations
He has collaborated with notable coworkers such as Arthur R. Mlodozeniec and Edward S. Lipinsky, contributing to the advancement of pharmaceutical technologies.
Conclusion
August Sturzenegger's work in pharmaceutical dosage forms exemplifies innovation and dedication to improving medication delivery systems. His patents reflect a commitment to quality and effectiveness in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
